Large cell neuroendocrine carcinoma originating in the subglottic larynx

Andrew Elton, Jenna Van Beck, Bin Li, Frank G. Ondrey

Research output: Contribution to journalArticlepeer-review

Abstract

Large cell neuroendocrine carcinoma (LCNEC) of the larynx is an exceedingly rare cancer of the head and neck that is difficult to diagnose. Few case reports of laryngeal LCNEC exist within the literature, and it was not until recently that LCNEC was recognized as a discrete subtype of neuroendocrine carcinoma. Given its recent recognition as a distinct subtype, histologic characteristics distinguishing LCNEC from other poorly differentiated carcinomas remain under investigation. Various reports have shown genetic alterations such as p53 and/or p16 overexpression, which are typically associated with infection by human papilloma virus (HPV). However, some reports have shown p53 and/or p16 overexpression in HPV negative samples. In this case, we discuss a 67-year-old patient with a history of extensive alcohol and tobacco use with a newly diagnosed T4N0M0, high grade, LCNEC of the subglottic larynx. Tumor pathology demonstrated positive staining for typical neuroendocrine (NE) markers like synaptophysin and chromogranin A; however, there was diffuse CK34βE12 and p16 expression. LCNEC is a newly classified subtype of poorly differentiated neuroendocrine (NE) tumors, and the diagnosis requires consideration of the clinical presentation, microscopic features, and immunostaining markers.

Original languageEnglish (US)
JournalEar, Nose and Throat Journal
DOIs
StateAccepted/In press - 2022

Bibliographical note

Publisher Copyright:
© The Author(s) 2022.

Keywords

  • large cell neuroendocrine carcinoma
  • laryngeal carcinoma
  • neuroendocrine tumor
  • subglottic larynx

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Large cell neuroendocrine carcinoma originating in the subglottic larynx'. Together they form a unique fingerprint.

Cite this